236 related articles for article (PubMed ID: 8799171)
21. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene.
Lin JJ; Jiang H; Fisher PB
Gene; 1998 Jan; 207(2):105-10. PubMed ID: 9511750
[TBL] [Abstract][Full Text] [Related]
22. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.
Kang DC; Gopalkrishnan RV; Wu Q; Jankowsky E; Pyle AM; Fisher PB
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):637-42. PubMed ID: 11805321
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
[TBL] [Abstract][Full Text] [Related]
24. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells.
Huang F; Adelman J; Jiang H; Goldstein NI; Fisher PB
Oncogene; 1999 Jun; 18(23):3546-52. PubMed ID: 10376533
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
Saeki T; Mhashilkar A; Swanson X; Zou-Yang XH; Sieger K; Kawabe S; Branch CD; Zumstein L; Meyn RE; Roth JA; Chada S; Ramesh R
Oncogene; 2002 Jul; 21(29):4558-66. PubMed ID: 12085234
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.
Li YJ; Liu G; Xia L; Xiao X; Liu JC; Menezes ME; Das SK; Emdad L; Sarkar D; Fisher PB; Archer MC; Zacksenhaus E; Ben-David Y
Oncotarget; 2015 Nov; 6(35):36943-54. PubMed ID: 26460950
[TBL] [Abstract][Full Text] [Related]
27. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH.
Kang D; Jiang H; Wu Q; Pestka S; Fisher PB
Gene; 2001 Apr; 267(2):233-42. PubMed ID: 11313150
[TBL] [Abstract][Full Text] [Related]
29. Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy.
Madireddi MT; Su ZZ; Young CS; Goldstein NI; Fisher PB
Adv Exp Med Biol; 2000; 465():239-61. PubMed ID: 10810631
[No Abstract] [Full Text] [Related]
30. Loss of MDA-7 expression with progression of melanoma.
Ellerhorst JA; Prieto VG; Ekmekcioglu S; Broemeling L; Yekell S; Chada S; Grimm EA
J Clin Oncol; 2002 Feb; 20(4):1069-74. PubMed ID: 11844832
[TBL] [Abstract][Full Text] [Related]
31. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene.
Kang DC; Gopalkrishnan RV; Lin L; Randolph A; Valerie K; Pestka S; Fisher PB
Oncogene; 2004 Mar; 23(9):1789-800. PubMed ID: 14676839
[TBL] [Abstract][Full Text] [Related]
32. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
[TBL] [Abstract][Full Text] [Related]
33. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.
Sauane M; Gopalkrishnan RV; Sarkar D; Su ZZ; Lebedeva IV; Dent P; Pestka S; Fisher PB
Cytokine Growth Factor Rev; 2003 Feb; 14(1):35-51. PubMed ID: 12485618
[TBL] [Abstract][Full Text] [Related]
34. Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma.
Allen M; Pratscher B; Roka F; Krepler C; Wacheck V; Schöfer C; Pehamberger H; Müller M; Lucas T
J Invest Dermatol; 2004 Sep; 123(3):583-8. PubMed ID: 15304100
[TBL] [Abstract][Full Text] [Related]
35. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.
Gupta P; Su ZZ; Lebedeva IV; Sarkar D; Sauane M; Emdad L; Bachelor MA; Grant S; Curiel DT; Dent P; Fisher PB
Pharmacol Ther; 2006 Sep; 111(3):596-628. PubMed ID: 16464504
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1.
Dash R; Su ZZ; Lee SG; Azab B; Boukerche H; Sarkar D; Fisher PB
Oncogene; 2010 Aug; 29(31):4412-23. PubMed ID: 20531301
[TBL] [Abstract][Full Text] [Related]
37. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.
Yacoub A; Mitchell C; Lister A; Lebedeva IV; Sarkar D; Su ZZ; Sigmon C; McKinstry R; Ramakrishnan V; Qiao L; Broaddus WC; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
Clin Cancer Res; 2003 Aug; 9(9):3272-81. PubMed ID: 12960112
[TBL] [Abstract][Full Text] [Related]
38. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
Jiang H; Lin JJ; Tao J; Fisher PB
Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844
[TBL] [Abstract][Full Text] [Related]
39. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
Ramesh R; Mhashilkar AM; Tanaka F; Saito Y; Branch CD; Sieger K; Mumm JB; Stewart AL; Boquoi A; Dumoutier L; Grimm EA; Renauld JC; Kotenko S; Chada S
Cancer Res; 2003 Aug; 63(16):5105-13. PubMed ID: 12941841
[TBL] [Abstract][Full Text] [Related]
40. Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.
Fisher PB; Sarkar D; Lebedeva IV; Emdad L; Gupta P; Sauane M; Su ZZ; Grant S; Dent P; Curiel DT; Senzer N; Nemunaitis J
Toxicol Appl Pharmacol; 2007 Nov; 224(3):300-7. PubMed ID: 17208263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
